InvestorsHub Logo
Followers 120
Posts 11104
Boards Moderated 0
Alias Born 01/20/2009

Re: TheShadow post# 1667

Thursday, 03/01/2018 10:33:55 AM

Thursday, March 01, 2018 10:33:55 AM

Post# of 1990
Don't search for a catch if there isn't any... This is very clear to me. Lummy is paying $1.5 mil to ARGS to get 7.5mil shares before the rs or 375,000 after the rs. ARGS will recueve $1,5mil Lummy will recieve 375,000 shares. What is so difficult about that?

"Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®
precision immunotherapy technology platform, today announced that it has signed a stock purchase agreement with Lummy (Hong Kong), Ltd. (“Lummy”), the Company’s partner for Rocapuldencel-T in China and certain other territories, under which the Company has agreed to issue and sell to Lummy in a private financing 7.5 million shares of the Company’s common stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares) for an aggregate purchase price of $1.5 million. The sale of the shares is expected to close on or prior to March 7, 2018. Lummy has agreed that, on the closing date, it will execute and deliver a lockup agreement under which it will agree not to sell, transfer or otherwise dispose of any shares of common stock of the Company for a period of 60 days from the closing date. The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares sold pursuant to the stock purchase agreement."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.